Payment overview · 2025
General Payments
12 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · KANSAS CITY, MO · NPI 1033352463
Verified facts
CMS Open Payments records show Brian Moore Haas, D.O received $6,792.32 in general payments during 2025 across 12 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
12 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $6,792.32 | 100.0% | 12 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $4,900.00 | 3 |
| Travel and Lodging | $1,855.07 | 6 |
| Food and Beverage | $37.25 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 470 | 64 |
| Atorvastatin Calcium | Atorvastatin Calcium | 433 | 78 |
| Furosemide | Furosemide | 420 | 74 |
| Potassium Chloride | Potassium Chloride | 419 | 76 |
| Amlodipine Besylate | Amlodipine Besylate | 334 | 67 |
| Levothyroxine Sodium | Levothyroxine Sodium | 332 | 54 |
| Gabapentin | Gabapentin | 315 | 63 |
| Tamsulosin Hcl | Tamsulosin Hcl | 285 | 62 |
| Pantoprazole Sodium | Pantoprazole Sodium | 234 | 52 |
| Lisinopril | Lisinopril | 216 | 39 |
| Carvedilol | Carvedilol | 199 | 41 |
| Trazodone Hcl | Trazodone Hcl | 185 | 37 |
| Sertraline Hcl | Sertraline Hcl | 184 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 154 | 39 |
| Duloxetine Hcl | Duloxetine Hcl | 150 | 28 |
| Metoprolol Succinate | Metoprolol Succinate | 148 | 44 |
| Mirtazapine | Mirtazapine | 145 | 32 |
| Donepezil Hcl | Donepezil Hcl | 143 | 27 |
| Jardiance | Empagliflozin | 138 | 16 |
| Spironolactone | Spironolactone | 135 | 26 |
| Tramadol Hcl | Tramadol Hcl | 129 | 35 |
| Buspirone Hcl | Buspirone Hcl | 126 | 24 |
| Losartan Potassium | Losartan Potassium | 125 | 32 |
| Cephalexin | Cephalexin | 120 | 55 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 117 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 113 | 27 |
| Metformin Hcl | Metformin Hcl | 105 | 22 |
| Famotidine | Famotidine | 104 | 30 |
| Lorazepam | Lorazepam | 101 | 55 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 100 | 40 |
| Finasteride | Finasteride | 94 | 12 |
| Xarelto | Rivaroxaban | 92 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 91 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 84 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 84 | 35 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 84 | 16 |
| Levetiracetam | Levetiracetam | 82 | 19 |
| Prednisone | Prednisone | 82 | 47 |
| Baclofen | Baclofen | 77 | 15 |
| Torsemide | Torsemide | 76 | 18 |
| Metoprolol Tartrate | Metoprolol Tartrate | 73 | 27 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 69 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 67 | 44 |
| Omeprazole | Omeprazole | 66 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 65 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 61 | 45 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 59 | 46 |
| Cefdinir | Cefdinir | 57 | 48 |
| Escitalopram Oxalate | Escitalopram Oxalate | 57 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 56 | 12 |
| Hydrochlorothiazide | Hydrochlorothiazide | 56 | 15 |
| Primidone | Primidone | 55 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 54 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 54 | 20 |
| Alprazolam | Alprazolam | 53 | 11 |
| Myrbetriq | Mirabegron | 53 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 52 | 49 |
| Allopurinol | Allopurinol | 49 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 46 | 31 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | 11 |
| Memantine Hcl | Memantine Hcl | 45 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 44 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 44 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 44 | suppressed |
| Pregabalin | Pregabalin | 42 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 21 |
| Sucralfate | Sucralfate | 40 | suppressed |
| Nystatin | Nystatin | 39 | 27 |
| Divalproex Sodium | Divalproex Sodium | 38 | 16 |
| Xtampza Er | Oxycodone Myristate | 36 | suppressed |
| Aripiprazole | Aripiprazole | 35 | suppressed |
| Lacosamide | Lacosamide | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | 11 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 34 | 12 |
| Olanzapine | Olanzapine | 34 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 34 | suppressed |
| Bumetanide | Bumetanide | 33 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 31 | suppressed |
| Bupropion Xl | Bupropion Hcl | 30 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | 12 |
| Levofloxacin | Levofloxacin | 30 | 24 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 19 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 14 |
| Topiramate | Topiramate | 28 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 26 | suppressed |
| Simvastatin | Simvastatin | 25 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 24 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Glucagon Emergency Kit | Glucagon | 24 | 15 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 23 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 23 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 23 | 11 |
| Benztropine Mesylate | Benztropine Mesylate | 22 | suppressed |
| Lactulose | Lactulose | 22 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Amantadine | Amantadine Hcl | 21 | suppressed |
| Glimepiride | Glimepiride | 21 | suppressed |
| Haloperidol | Haloperidol | 20 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 20 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 20 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Metolazone | Metolazone | 19 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 19 | suppressed |
| Loperamide | Loperamide Hcl | 18 | 12 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 18 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Minoxidil | Minoxidil | 17 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 16 | 16 |
| Risperidone | Risperidone | 16 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 16 | suppressed |
| Xifaxan | Rifaximin | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 15 | suppressed |
| Carbamazepine | Carbamazepine | 15 | suppressed |
| Clonazepam | Clonazepam | 15 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Januvia | Sitagliptin Phosphate | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | 12 |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Brinzolamide | Brinzolamide | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Risperidone Er | Risperidone Microspheres | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Tacrolimus | Tacrolimus | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $6,792.32 · 12 records | Otsuka America Pharmaceutical, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error